companydata.dkZelandia Life Science R&D Consulting ApS: Financial statements 2023
CVR: 40206051
Zelandia Life Science R&D Consulting ApS (CVR 40206051) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 965,311 and a net result of DKK 768,036 compared with DKK -92,207 the year before. Equity amounted to DKK 940,121. The solvency ratio was 65.6%.
- Gross Profit
- 965,311 kr.
- Profit/Loss
- 768,036 kr.
- Equity
- 940,121 kr.
- Total Assets
- 1,433,677 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 965 t. | 768 t. | 940 t. | - |
| 2022 | - | -78 t. | -92 t. | 172 t. | - |
| 2021 | - | 830 t. | 642 t. | 764 t. | - |
| 2020 | - | 307 t. | 236 t. | 322 t. | - |
| 2019 | - | 815 t. | 636 t. | 686 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Zelandia Life Science R&D Consulting ApS has published its annual report for 2022. Gross profit came to DKK -77,954, and the net result was DKK -92,207.
About Zelandia Life Science R&D Consulting ApS
Zelandia Life Science R&D Consulting ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kristian Tage Hansen. The company is owned by KTHolding ApS. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580.